sponsored byAAAS Golden Fund

EurekAlert!, a service of AAAS
Home About us
Advanced Search
23-Apr-2014 21:14
US Eastern Time

Username:

Password:

Register

Forgot Password?

Press Releases

Breaking News

Science Business

Grants, Awards, Books

Meetings

Multimedia

Science Agencies
on EurekAlert!

US Department of Energy

US National Institutes of Health

US National Science Foundation

Calendar

Submit a Calendar Item

Subscribe/Sponsor

Links & Resources

Portals

RSS Feeds

Accessibility Option On

Options

Portal Home

Glossary

Background Articles

Research Papers

Meetings

Links & Resources

Portal: Disease in the Developing World

News Releases

Key: Meeting M      Journal J      Funder F

Showing releases 726-750 out of 884.

<< < 25 | 26 | 27 | 28 | 29 | 30 | 31 | 32 | 33 | 34 > >>

Public Release: 16-Aug-2012
Immunity
Discovery of immune cells that protect against multiple sclerosis offers hope for new treatment
Immune cells called dendritic cells, which were previously thought to contribute to the onset and development of multiple sclerosis, actually protect against the disease in a mouse model, according to a study published by Cell Press in the August issue of the journal Immunity. These new insights change our fundamental understanding of the origins of multiple sclerosis and could lead to the development of more effective treatments for the disease.

Contact: Lisa Lyons
elyons@cell.com
617-386-2121
Cell Press

Public Release: 16-Aug-2012
Lancet
World's largest tobacco use study: Tobacco control remains major challenge
An international survey of tobacco use in three billion individuals, published in the current issue of the Lancet, demonstrates an urgent need for policy change in low- and middle-income countries, according to the University at Buffalo professor who led the research.
Various

Contact: Ellen Goldbaum
goldbaum@buffalo.edu
716-645-4605
University at Buffalo

Public Release: 16-Aug-2012
Cell
Poxviruses defeat antiviral defenses by duplicating a gene
Scientists have discovered that poxviruses, which are responsible for smallpox and other diseases, can adapt to defeat different host antiviral defenses by quickly and temporarily producing multiple copies of a gene that helps the viruses to counter host immunity.

Contact: Phil Sahm
phil.sahm@hsc.utah.edu
801-581-2517
University of Utah Health Sciences

Public Release: 15-Aug-2012
Cell Host & Microbe
Duke scientists discover genetic material in blood cells that may affect malaria parasites
Researchers at Duke University Medical Center may finally have discovered why people with sickle cell disease get milder cases of malaria than individuals who have normal red blood cells. In a finding that has eluded scientists for years, Duke researchers discovered that genetic material in red blood cells may help alter parasite activity via a novel mechanism that alters parasite gene regulation.
Duke Chancellor's Pilot Project, Roche Foundation for Anemia Research, Burroughs Welcome Fund, Doris Duke Charitable Foundation

Contact: Mary Jane Gore
mary.gore@duke.edu
919-660-1309
Duke University Medical Center

Public Release: 15-Aug-2012
Alcoholism: Clinical & Experimental Research
Tracking the effects of prenatal alcohol exposure through to 9 years of age
Although studies of alcohol's effects on fetal growth have consistently demonstrated deficits that persist through infancy, the data on long-term postnatal growth from human studies have been inconsistent. A new study of the effects of heavy prenatal alcohol exposure on growth and body composition throughout childhood has found growth restrictions that persist through to nine years of age, as well as a delay in weight gain during infancy, both of which were exacerbated by iron deficiency.
NIH/National Institute on Alcohol Abuse and Alcoholism, NIH/Office of Research

Contact: R. Colin Carter, M.D.
robertcolin.carter@childrens.harvard.edu
617-355-6624
Alcoholism: Clinical & Experimental Research

Public Release: 14-Aug-2012
Lancet
Nurses as effective as doctors in treatment of HIV patients
Nurse-centered care of HIV patients can be just as safe and effective as care delivered by doctors and has a number of specific health benefits, according to a new study led by the University of East Anglia and the University of Cape Town.
Medical Research Council, Development Cooperation Ireland, Canadian International Development Agency

Contact: Simon Dunford
s.dunford@uea.ac.uk
44-160-359-2203
University of East Anglia

Public Release: 10-Aug-2012
International Journal of Tuberculosis and Lung Disease
New approach of resistant tuberculosis
Scientists of the Antwerp Institute of Tropical Medicine have breathed new life into a forgotten technique and so succeeded in detecting resistant tuberculosis in circumstances where so far this was hardly feasible. Tuberculosis bacilli that have become resistant against our major antibiotics are a serious threat to world health.
Damien Foundation

Contact: prof Bouke De Jong
bdejong@itg.be
32-324-76590
Institute of Tropical Medicine Antwerp

Public Release: 9-Aug-2012
Journal of the Pediatric Infectious Diseases Society
First antibiotic stewardship probed in the Journal of the Pediatric Infectious Diseases Society
The articles address: Impact of prospective-audit-with-feedback program and clinician attitudes toward program.

Contact: Jodie Klein
jodieklein@kleinonpoint.com
703-528-3333
Pediatric Infectious Diseases Society

Public Release: 9-Aug-2012
Wastewater key to quenching global thirst, UCI-led review finds
Parched cities and regions across the globe are using sewage effluent and other wastewater in creative ways to augment drinking water, but 4 billion people still do not have adequate supplies, and that number will rise in coming decades. Wildlife, rivers and ecosystems are also being decimated by the ceaseless quest for new water and disposal of waste. Changing human behavior and redoubling use of alternatives are critical to breaking that cycle.

Contact: Janet Wilson
janethw@uci.edu
949-824-3969
University of California - Irvine

Public Release: 7-Aug-2012
Clinical trial for rabies monoclonal antibody
A clinical trial for an anti-rabies human monoclonal antibody developed through a partnership between MassBiologics (UMass Medical School) and the Serum Institute of India is enrolling patients. The study, sponsored by the Serum Institute, will evaluate post-exposure prophylaxis following rabies exposure compared to standard treatment. Post-exposure prophylaxis for rabies that includes a monoclonal antibody should provide a more affordable, safer alternative to this world-wide public health problem, which impacts 10 million people a year.

Contact: Mark L. Shelton
mark.shelton@umassmed.edu
508-856-2000
University of Massachusetts Medical School

Public Release: 5-Aug-2012
Nature Genetics
Out of Europe
Researchers show that access to clean water might not reduce the incidence of dysentry as a country becomes more developed. As countries become more industrialized, and improve health, lifestyle and access to clean water, the numbers of infections with dysentery-causing Shigella flexneri decline. However, incidence of another form of the dysentery-causing bacterium, Shigella sonnei, increase with these improvements.
Wellcome Trust, Victorian Government

Contact: Aileen Sheehy
press.office@sanger.ac.uk
44-012-234-96928
Wellcome Trust Sanger Institute

Public Release: 2-Aug-2012
International Journal of Computational Science and Engineering
Detecting thyroid disease by computer
Researchers in India have developed an improved expert system for the diagnosis of thyroid disease. They describe details of their approach to screening medical data in a forthcoming issue of the International Journal of Computational Science and Engineering.

Contact: Nallamuthu Rajkumar
rknpsna@gmail.com
Inderscience Publishers

Public Release: 2-Aug-2012
5-year survey confirms Uruguay's world-leading tobacco control strategy is delivering results
The International Tobacco Control Policy Evaluation Project today launched a new report on the effectiveness of tobacco control policies in Uruguay. The ITC Uruguay Survey found that the country's world-leading, comprehensive tobacco control strategy has had positive effects on raising awareness of the true harms of smoking, reducing mis-perceptions about "light/mild" cigarettes, reducing exposure to secondhand smoke, and reducing the demand for tobacco products through tax increases.

Contact: Tracey Johnston
traceyj1@hotmail.com
44-077-623-10248
University of Waterloo

Public Release: 1-Aug-2012
PLOS Neglected Tropical Diseases
Global health researchers urge integrating de-worming into HIV care in Africa
An estimated 50 percent of the 2.1 million children with HIV infections in sub-Saharan African also have worm infestations. Such parasites have many health and child development repercussions, including hastening the progression of HIV. Proven interventions, including routine de-worming among children could effectively be integrated into HIV care. Global health researchers see this as a missed opportunity to treat a neglected tropical disease. School programs are not as effective in carrying out this public health intervention because they miss toddlers and pre-schoolers.
Research Resources, National Institutes of Health

Contact: Bobbi Nodell
bnodell@uw.edu
206-543-7129
University of Washington

Public Release: 1-Aug-2012
Malaria Journal
New research reveals extent of poor-quality antimalarial medicines in South American countries
Two articles recently published in Malaria Journal shed new light on the quality of antimalarial medicines circulating in countries in the Amazon Basin in South America. Researchers from the Promoting the Quality of Medicines program, a cooperative agreement between the US Agency for International Development and the US Pharmacopeial Convention, in conjunction with country partners, coordinated these studies in the context of the Amazon Malaria Initiative.
USAID, US Pharmacopeia

Contact: Theresa Laranang-Mutlu
trl@usp.org
301-816-8167
US Pharmacopeia

Public Release: 1-Aug-2012
Sleep
Global 'sleeplessness epidemic' affects an estimated 150 million in developing world
Levels of sleep problems in the developing world are approaching those seen in developed nations, linked to an increase in problems like depression and anxiety.

Contact: Anna Blackaby
a.blackaby@warwick.ac.uk
44-024-765-75910
University of Warwick

Public Release: 1-Aug-2012
American Journal of Tropical Medicine and Hygiene
New study finds strong evidence of humans surviving rabies bites without treatment
Challenging conventional wisdom that rabies infections are 100 percent fatal unless immediately treated, scientists studying remote populations in the Peruvian Amazon at risk of rabies from vampire bats found 11 percent of those tested showed protection against the disease, with only one person reporting a prior rabies vaccination. Ten percent appear to have survived exposure to the virus without any medical intervention. The findings from investigators at the CDC published by the American Journal of Tropical Medicine and Hygiene.

Contact: Bridget DeSimone
bdesimone@burnesscommunications.com
301-280-5735
Burness Communications

Public Release: 31-Jul-2012
XIX International AIDS Conference
Early treatment could mean greater earning potential for people with HIV
In a first-of-its-kind health campaign in Uganda, researchers from the University of North Carolina at Chapel Hill show that adults with HIV who had less severe infections could work more hours per week, and their children were more likely to be enrolled in school.

Contact: Thania Benios
thania_benios@unc.edu
919-962-8596
University of North Carolina at Chapel Hill

Public Release: 31-Jul-2012
PLOS Biology
Vaccine research shows vigilance needed against evolution of more-virulent malaria
Malaria parasites evolving in vaccinated laboratory mice become more virulent, according to research at Penn State University. The mice were injected with a critical component of several candidate human malaria vaccines that now are being evaluated in clinical trials.
Penn State University

Contact: Barbara K. Kennedy
sciencew@psu.edu
814-863-4682
Penn State

Public Release: 28-Jul-2012
World Hepatitis Day - EASL calls on the United Nations to join the effort to tackle viral hepatitis
Marking World Hepatitis Day, the European Association for the Study of the Liver calls on the different organizations which make up the United Nations systems to take action to fight against Viral Hepatitis (Hepatitis B and C), a potentially fatal infection of the liver which affects 500 million people.

Contact: Margaret Walker
margaret.walker@easloffice.eu
European Association for the Study of the Liver

Public Release: 27-Jul-2012
Antimicrobial Agents and Chemotherapy
UCLA researchers discover that fluoxetine -- a.k.a., Prozac -- is effective as an anti-viral
Using molecular screening of small molecule libraries, a team of researchers at UCLA from the departments of Pediatrics, the California NanoSystems Institute, and Molecular and Medical Pharmacology has been able to identify fluoxetine (commonly known as Prozac), a selective serotonin reuptake inhibitor, as a potent inhibitor of coxsackievirus replication.

Contact: Jennifer Marcus
jmarcus@cnsi.ucla.edu
310-267-4839
University of California - Los Angeles

Public Release: 27-Jul-2012
XIX International AIDS Conference (AIDS 2012)
Swaziland HIV incidence results announced at AIDS 2012
The results from a nationally representative HIV incidence study in Swaziland indicate that the national rate of new HIV infections is 2.38 percent among adults ages 18-49. This figure, comparable to the 2009 UNAIDS estimate of 2.66 percent for Swaziland adults ages 15-49, suggests that the HIV epidemic in Swaziland may have begun to stabilize in the past few years. The findings of the Swaziland HIV Incidence Measurement Survey were presented today at the XIX International AIDS Conference in Washington DC.
Centers for Disease Control, PEPFAR

Contact: Stephanie Berger
sb2247@columbia.edu
212-305-4372
Columbia University's Mailman School of Public Health

Public Release: 26-Jul-2012
XIX International AIDS Conference
Early HIV treatment may improve socioeconomic conditions in rural sub-saharan Africa
Adults with HIV in rural sub-Saharan Africa who receive antiretroviral drugs early in their infection may reap benefits in their ability to work and their children's ability to stay in school, according to a first-of-its-kind clinical study in Uganda that compared socioeconomic outcomes with CD4+ counts -- a standard measure of health status for people with HIV.

Contact: Jason Socrates Bardi
jason.bardi@ucsf.edu
415-502-6397
University of California - San Francisco

Public Release: 24-Jul-2012
Undergrads invent cell phone screener to combat anemia in developing world
Biomedical engineering students have invented a way to use cell phones in developing nations to identify pregnant women with dangerous anemia.
Jhpiego

Contact: Phil Sneiderman
prs@jhu.edu
443-287-9960
Johns Hopkins University

Public Release: 24-Jul-2012
Journal of Biological Chemistry
Under the right conditions, peptide blocks HIV infection at multiple points along the way
Using model cell lines, a research group at Emory University showed that human neutrophil peptide 1 effectively prevented HIV entry into cells in multiple ways.

Contact: Angela Hopp
240-283-6614
American Society for Biochemistry and Molecular Biology

Showing releases 726-750 out of 884.

<< < 25 | 26 | 27 | 28 | 29 | 30 | 31 | 32 | 33 | 34 > >>